Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer
Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal bevacizumab treatment for delayed radiation maculopa...
Enregistré dans:
Auteurs principaux: | Gondo M, Sakai T, Tsuneoka H, Kanehira C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f5227cc382474f8ebf9f507187229834 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
par: Shah NV, et autres
Publié: (2012) -
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
par: Kim M, et autres
Publié: (2013) -
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
par: Shah NV, et autres
Publié: (2013) -
Central serous papillopathy by optic nerve head drusen
par: Ana Marina Suelves, et autres
Publié: (2010) -
Case of endophthalmitis following intravitreal injections of bevacizumab
par: Shinya Komori, et autres
Publié: (2010)